diff options
| author | Jesús <heckyel@hyperbola.info> | 2021-02-04 22:31:05 -0500 |
|---|---|---|
| committer | Jesús <heckyel@hyperbola.info> | 2021-02-04 22:31:05 -0500 |
| commit | c6a094ee3d27e5741e96bcb0939a61e57835d3a5 (patch) | |
| tree | 77c2df7187734362bb2ae1c6bf9e6169f66fd863 | |
| parent | 79972b5a674f32aadc7054de2ffcd5626f773dda (diff) | |
| download | notcovid19-c6a094ee3d27e5741e96bcb0939a61e57835d3a5.tar.lz notcovid19-c6a094ee3d27e5741e96bcb0939a61e57835d3a5.tar.xz notcovid19-c6a094ee3d27e5741e96bcb0939a61e57835d3a5.zip | |
Add new docs
| -rw-r--r-- | README.md | 35 | ||||
| -rw-r--r-- | docs/C4591001_Clinical_Protocol_Nov2020.pdf | bin | 0 -> 1373819 bytes |
2 files changed, 20 insertions, 15 deletions
@@ -47,23 +47,26 @@ ## Docs -| Name | SRC link | Local link | Language | -| :---------------------------------------------------------------------------------------------------------------------------------------------------------------------: | :--------: | :--------: | :------: | -| COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations | [URL][d0] | [URL][l0] | EN | -| How Long Should Social Distancing Last? Predicting Time to Moderation, Control, and Containment of COVID-19 | [URL][d1] | [URL][l1] | EN | -| Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 | [URL][d2] | [URL][l2] | EN | -| Will Coronavirus Pandemic Diminish by Summer? | [URL][d3] | [URL][l3] | EN | -| Stability of SARS-CoV-2 in different environmental conditions | [URL][d4] | [URL][l4] | EN | -| The proximal origin of SARS-CoV-2 | [URL][d5] | [URL][l5] | EN | -| Letter: Thrombotic Neurovascular Disease in COVID-19 Patients | [URL][d6] | [URL][l6] | EN | -| Draft landscape of COVID-19 candidate vaccines | [URL][d7] | [URL][l7] | EN | -| Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases | [URL][d8] | [URL][l8] | EN | -| Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia | [URL][d9] | [URL][l9] | EN | - - -## Hypothetical vaccine +| Name | SRC link | Local link | Language | +| :---------------------------------------------------------------------------------------------------------------------------------------------------------------------: | :--------: | :--------: | :------: | +| COVID-19: IFRC, UNICEF and WHO issue guidance to protect children and support safe school operations | [URL][d0] | [URL][l0] | EN | +| How Long Should Social Distancing Last? Predicting Time to Moderation, Control, and Containment of COVID-19 | [URL][d1] | [URL][l1] | EN | +| Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 | [URL][d2] | [URL][l2] | EN | +| Will Coronavirus Pandemic Diminish by Summer? | [URL][d3] | [URL][l3] | EN | +| Stability of SARS-CoV-2 in different environmental conditions | [URL][d4] | [URL][l4] | EN | +| The proximal origin of SARS-CoV-2 | [URL][d5] | [URL][l5] | EN | +| Letter: Thrombotic Neurovascular Disease in COVID-19 Patients | [URL][d6] | [URL][l6] | EN | +| Draft landscape of COVID-19 candidate vaccines | [URL][d7] | [URL][l7] | EN | +| Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases | [URL][d8] | [URL][l8] | EN | +| Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia | [URL][d9] | [URL][l9] | EN | +| A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-COV-2rna vaccine candidates against COVID-19 in healthy individuals | [URL][d10] | [URL][l10] | EN | + +## vaccine [mRNA1273](https://en.wikipedia.org/wiki/MRNA-1273) +[Sputnik V](https://en.wikipedia.org/wiki/Sputnik_V_COVID-19_vaccine) +[Pfizer](https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine) + ### References @@ -122,4 +125,6 @@ title="GNU Free Documentation License">GFDLv1.3+</abbr></a> License [l8]: docs/sentinel-surveillance-of-SARS-CoV-2.pdf [d9]: https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2900234-8 [l9]: docs/PIIS0140673621002348.pdf +[d10]: https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf +[l10]: docs/C4591001_Clinical_Protocol_Nov2020.pdf [genome]: https://github.com/Hikoyu/SARS-CoV-2 diff --git a/docs/C4591001_Clinical_Protocol_Nov2020.pdf b/docs/C4591001_Clinical_Protocol_Nov2020.pdf Binary files differnew file mode 100644 index 0000000..278bd15 --- /dev/null +++ b/docs/C4591001_Clinical_Protocol_Nov2020.pdf |